2024 PC3I Innovation Accelerator Request for Proposals
November 10, 2023
The Penn Cancer Innovation Accelerator program is now open for proposals through November 2023. Teams from across the world of cancer care at Penn Medicine suggest pain points that, if successfully addressed, would have a major positive impact on patients, care teams, and/or the health system as a whole.
If chosen, teams work side-by-side with PC3I staff to apply innovation methodologies and project management tools to the problem at hand. Together, they work towards creating, testing, and scaling solutions to real clinical opportunities within the health system.
Selected projects will be staffed by an Innovation Manager (up to 50% time) and additional PC3I team members as needed. In addition, PC3I will provide up to $60,000 in funding to help accomplish project goals.
Past Projects
Past Innovation Accelerator Projects include:
Contact
If you have any questions, please email PC3I@pennmedicine.upenn.edu
The Penn Center for Cancer Care Innovation (PC3I) is the nation’s first group working at the nexus of research and practice to develop solutions to transform cancer care delivery. Founded at the Abramson Cancer Center at the University of Pennsylvania, our mission is to make cancer care better for patients, clinicians, and communities.
Penn Medicine’s Abramson Cancer Center (ACC) is a world leader in cancer research, patient care, and education. Founded in 1973, its mission is to improve the lives of adults and children with cancer in the greater Philadelphia area, across the nation, and around the world. PC3I works closely with leadership within the ACC and the entire cancer service line at Penn.
